Back    Zoom +    Zoom -
石四藥(02005.HK)就兩款2類化學改良型新藥潛在合作簽訂意向書
Recommend
2
Positive
1
Negative
0
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!
石四藥(02005.HK)公布，全資附屬已與鑫正合盈就有關一款2.2類適用於兒童的解痙藥以及一款2.3類目標為慢性阻塞性肺疾病的藥物之兩款2類化學改良型新藥的潛在合作簽訂一份意向書。(ha/da)

Switch to Auto-Translated Version
AASTOCKS新聞
  • Remark
  • (1) HK Indices are real time
Home|RT Quote|Market|News|Indices
Feedback|Disclaimer
View: Mobile|Desktop
Lang: 繁|简|EN
Back To Top
Contact Us
Email: support@aastocks.com